Skip to main content
. 2017 Jul 14;23(26):4831–4838. doi: 10.3748/wjg.v23.i26.4831

Table 2.

Tumour features n (%)

Whole study group Survival in 5-yr follow-up
Stage
I 18 (15.3) 15 (83.3)
II 48 (40.7) 37 (77.1)
III 30 (25.4) 16 (53.3)
IV 22 (18.6) 3 (13.6)
Grade
I 17 (14.4) 13 (76.5)
II 86 (72.9) 53 (61.6)
III 14 (11.9) 5 (35.7)
Data missing 1 (0.8) 0 (0)
Lymph node metastasis
No 72 (61.0) 53 (73.6)
Yes 46 (39.0) 18 (39.1)
Distant metastasis
No 96 (81.4) 68 (70.8)
Yes 22 (18.6) 3 (13.6)
Mucinous carcinoma
No 99 (83.9) 59 (59.6)
Yes 10 (8.5) 6 (60.0)
Data missing 9 (7.6)